Traws Pharma, Inc. Common Stock
$0.49
Market Cap
$7.53M
Shares Outstanding
15.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 25, 2013
Round Lot
100
Locale
US
Day Open
$0.54
Day High
$0.55
Day Low
$0.48
Volume
193.8K
VWAP
$0.50
Prev Close
$0.54
Transactions
--
Acc. Volume
--
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. The company has four clinical programs: (i) tivoxavir marboxil, (ii) ratutrelvir, (iii) narazaciclib (ON 123300), and (iv) rigosertib. It is focused on the development of tivoxavir marboxil and ratutrelvir. The company derives revenue from its collaboration and licensing agreements.
Traws Pharma, Inc. Common Stock (TRAW) closed the 2026-09-18 session at $0.49, down 8.50% versus the previous close (-0.05). The stock opened at $0.54 and traded between $0.48 and $0.55 during that session. Session trading volume was 194K shares. The volume-weighted average price (VWAP) is $0.50.
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. The company has four clinical programs: (i) tivoxavir marboxil, (ii) ratutrelvir, (iii) narazaciclib (ON 123300), and (iv) rigosertib. It is focused on the development of tivoxavir marboxil and ratutrelvir. The company derives revenue from its collaboration and licensing agreements.
Traws Pharma, Inc. Common Stock has a market capitalization of $7.5 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. TRAW is listed on the XNAS exchange. The company employs approximately 7 people. Traws Pharma, Inc. Common Stock is headquartered in NEWTOWN, PA. The recorded listing date is 2013-07-25.
On this page you can find market TRAW stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.